- Home
- TIL vs DERM Comparison
TIL vs DERM Comparison
Compare TIL & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- DERM
- Stock Information
- Founded
- TIL 2018
- DERM 2014
- Country
- TIL United States
- DERM United States
- Employees
- TIL N/A
- DERM N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- TIL Health Care
- DERM Health Care
- Exchange
- TIL Nasdaq
- DERM Nasdaq
- Market Cap
- TIL 171.7M
- DERM 140.0M
- IPO Year
- TIL 2021
- DERM 2021
- Fundamental
- Price
- TIL $15.46
- DERM $6.25
- Analyst Decision
- TIL Buy
- DERM Strong Buy
- Analyst Count
- TIL 5
- DERM 2
- Target Price
- TIL $114.00
- DERM $10.00
- AVG Volume (30 Days)
- TIL 78.2K
- DERM 103.6K
- Earning Date
- TIL 05-09-2025
- DERM 05-12-2025
- Dividend Yield
- TIL N/A
- DERM N/A
- EPS Growth
- TIL N/A
- DERM N/A
- EPS
- TIL N/A
- DERM N/A
- Revenue
- TIL N/A
- DERM $56,134,000.00
- Revenue This Year
- TIL N/A
- DERM $29.83
- Revenue Next Year
- TIL N/A
- DERM $54.88
- P/E Ratio
- TIL N/A
- DERM N/A
- Revenue Growth
- TIL N/A
- DERM N/A
- 52 Week Low
- TIL $9.62
- DERM $3.20
- 52 Week High
- TIL $92.00
- DERM $7.29
- Technical
- Relative Strength Index (RSI)
- TIL 44.19
- DERM 53.65
- Support Level
- TIL $14.96
- DERM $5.98
- Resistance Level
- TIL $18.71
- DERM $6.40
- Average True Range (ATR)
- TIL 1.80
- DERM 0.62
- MACD
- TIL 0.09
- DERM -0.06
- Stochastic Oscillator
- TIL 46.32
- DERM 36.97
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.